Therefore, the combination of cisplatin and irradiation, in conjunction with postirradiation anti–PD-1 treatment, elicited antitumor effects in nonirradiated left hindlimb tumors, in which the expression of cytotoxic T cells was increased in the tumor microenvironment. The gene discussed is PDCD1; the disease is neoplasm.